<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T16:57:05Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/57167" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/57167</identifier><datestamp>2024-12-05T22:07:02Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2024-12-05T22:07:02Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_10459.1_57167">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10459.1/57167</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Vitamin D receptor levels in colorectal cancer. Possible role of BsmI polymorphism</dc:title>
               <dc:creator>Parisi Capdevila, Eva</dc:creator>
               <dc:creator>Reñé Espinet, Josep Maria</dc:creator>
               <dc:creator>Cardús i Figueras, Anna</dc:creator>
               <dc:creator>Valcheva, Petya</dc:creator>
               <dc:creator>Piñol Felis, Carme</dc:creator>
               <dc:creator>Valdivielso Revilla, José Manuel</dc:creator>
               <dc:creator>Fernández i Giráldez, Elvira</dc:creator>
               <dc:subject>Vitamin D</dc:subject>
               <dc:subject>Colon cancer</dc:subject>
               <dc:subject>VDR</dc:subject>
               <dc:subject>Bsml</dc:subject>
               <dc:description>A high expression of vitamin D receptor (VDR) in colorectal cancer (CRC) tumoral tissue has been related&#xd;
to a good prognosis and it has been proposed that it could be a good biological marker of CRC progression.&#xd;
Nevertheless, there are no previous studies that compare the VDR expression in tumoral towards normal&#xd;
tissue of the same CRC patient in relation to VDR BsmI genotype.&#xd;
We collected normal and tumoral tissue samples, as well as blood samples, from CRC patients (n = 170)&#xd;
and controls (n = 122). VDR genotyping was performed and BsmI homozygous patients were selected&#xd;
(CRC = 50, Cont = 32). VDR mRNA and protein levels were analyzed. We also measured 25-Hydroxyvitamin&#xd;
D serum levels.&#xd;
We found no differences in the polymorphism distribution in tumoral versus normal tissue (control:&#xd;
BB = 15.7%, bb = 41.3%, Bb = 43%; CRC: BB = 14.2%, bb = 41.9%, Bb = 43.9%). Furthermore, VDR levels decreased&#xd;
in colonic cancer tissue (mean: 3.03) versus normal mucosa (11.62) from the same patient (p &lt; 0.001),&#xd;
but this decrease was similar in both genotypes. There were differences in 25-Hydroxyvitamin D3 levels&#xd;
between the CRC and the control group (CRC = 8.65 ng/ml, Cont = 18.15 ng/ml).&#xd;
In conclusion, we found a decrease in VDR levels in tumoral compared with normal mucosa from the&#xd;
same patient. This difference is independent of the BsmI polymorphism.</dc:description>
               <dc:description>This work was supported by Fundacio Dr Pifarré grants, FIS ´ PI07/0427, PI06/0010 and REDINREN (16/06).</dc:description>
               <dc:date>2024-12-05T22:07:02Z</dc:date>
               <dc:date>2024-12-05T22:07:02Z</dc:date>
               <dc:date>2016-06-06T11:01:37Z</dc:date>
               <dc:date>2025-01-01</dc:date>
               <dc:date>2008</dc:date>
               <dc:type>article</dc:type>
               <dc:type>publishedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/10459.1/57167</dc:identifier>
               <dc:relation>Reproducció del document publicat a https://doi.org/10.1016/j.jsbmb.2008.05.001</dc:relation>
               <dc:relation>Journal of Steroid Biochemistry &amp; Molecular Biology, 2008, vol. 111, núm. 1-2, p. 87-90</dc:relation>
               <dc:rights>(c) Elsevier, 2008</dc:rights>
               <dc:rights>info:eu-repo/semantics/restrictedAccess</dc:rights>
               <dc:publisher>Elsevier</dc:publisher>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>